Detalles de la búsqueda
1.
The age-dependent immunogenicity after two doses of MVC-COV1901 vaccine.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267573
2.
First-in-Human Trial of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine with Adjuvant of Aluminum Hydroxide and CpG 1018
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21254668
3.
Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21254000
4.
Protection of Hamsters Challenged with SARS-CoV-2 after Two Doses of MVC-COV1901 Vaccine Followed by a Single Intranasal Booster with Nanoemulsion Adjuvanted S-2P Vaccine
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-481901
5.
Neutralization of SARS-CoV-2 Omicron BA.4/BA.5 subvariant by a booster dose of bivalent adjuvanted subunit vaccine containing Omicron BA.4/BA.5 and BA.1 subvariants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-511263
6.
Intranasal Nanoemulsion Adjuvanted S-2P Vaccine Demonstrates Protection in Hamsters and Induces Systemic, Cell-Mediated and Mucosal Immunity in Mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-485323
7.
Protection of Hamsters Challenged with SARS-CoV-2 Variants of Concern by Two Doses of MVC-COV1901 Vaccine Followed by a Single Dose of Beta Variant Version of MVC-COV1901
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-462344
8.
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-425674
Resultados
1 -
8
de 8
1
Próxima >
>>